Evidence map›Paper›PMID 37029696›Full record

ArticleJournal of biomedical materials research. Part A2023

Novel HALO® image analysis to determine cell phenotype in porous precision-templated scaffolds.

Nathan R Chan, Billanna Hwang, Rachel L Waworuntu, An J Tran, Buddy D Ratner, James D Bryers

Open access · greenAbstract read
In one paragraph

Article in Journal of biomedical materials research. Part A, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Nathan R ChanMolecular Engineering and Sciences Institute, University of Washington, Seattle, Washington, USA.
Billanna HwangCenter for Lung Biology, University of Washington, Seattle, Washington, USA.
Rachel L WaworuntuCenter for Lung Biology, University of Washington, Seattle, Washington, USA.
An J TranCenter for Lung Biology, University of Washington, Seattle, Washington, USA.
Buddy D RatnerMolecular Engineering and Sciences Institute, University of Washington, Seattle, Washington, USA.
James D BryersMolecular Engineering and Sciences Institute, University of Washington, Seattle, Washington, USA.ORCID 0000-0003-3332-3271
University of Washington · US

Funding

Periodontal Biomaterials with BITE (Biofilm Immunity with Tissue Engineering)R01DE018701 · NIDCR · UNIVERSITY OF WASHINGTON · PI BRYERS, JAMES D. · 2008 to 2019
$5.0M
Tissue Regeneration by Engineered Extracellular VesiclesR01GM128991 · NIGMS · UNIVERSITY OF WASHINGTON · PI BRYERS, JAMES D. · 2019 to 2022
$1.9M
NIDCR NIH HHS R01 DE018701NIGMS NIH HHS R01 GM128991
6 · The paper itself

Abstract

Image analysis platforms have gained increasing popularity in the last decade for the ability to automate and conduct high-throughput, multiplex, and quantitative analyses of a broad range of pathological tissues. However, imaging tissues with unique morphology or tissues containing implanted biomaterial scaffolds remain a challenge. Using HALO®, an image analysis platform specialized in quantitative tissue analysis, we have developed a novel method to determine multiple cell phenotypes in porous precision-templated scaffolds (PTS). PTS with uniform spherical pores between 30 and 40 μm in diameter have previously exhibited a specific immunomodulation of macrophages toward a pro-healing phenotype and an overall diminished foreign body response (FBR) compared to PTS with larger or smaller pore sizes. However, signaling pathways orchestrating this pro-healing in 40 μm PTS remain unclear. Here, we use HALO® to phenotype PTS resident cells and found a decrease in pro-inflammatory CD86 and an increase in pro-healing CD206 expression in 40 μm PTS compared to 100 μm PTS. To understand the mechanisms that drive these outcomes, we investigated the role of myeloid-differentiation-primary-response gene 88 (MyD88) in regulating the pro-healing phenomenon observed only in 40 μm PTS. When subcutaneously implanted in MyD88KO mice, 40 μm PTS reduced the expression of CD206, and the scaffold resident cells displayed an average larger nuclear size compared to 40 μm PTS implanted in mice expressing MyD88. Overall, this study demonstrates a novel image analysis method for phenotyping cells within PTS and identifies MyD88 as a critical mediator in the pore-size-dependent regenerative healing and host immune response to PTS.

Indexed as

Biocompatible MaterialsMyeloid Differentiation Factor 88AnimalsMicePhenotypePorosityProstheses and ImplantsTissue ScaffoldsBiocompatible MaterialsMyeloid Differentiation Factor 88biomaterial scaffoldscell phenotypeforeign body responsemacrophage polarizationMyD88

Identifiers

PMID37029696
PMCPMC10524297
OpenAlexW4362716682

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.